CNMD250117C80000
- 1.85
- 0.000.00%
ConMed Newsroom
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating
The Three-year Underlying Earnings Growth at CONMED (NYSE:CNMD) Is Promising, but the Shareholders Are Still in the Red Over That Time
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Is It Too Late To Consider Buying CONMED Corporation (NYSE:CNMD)?
ConMed To Go Ex-Dividend On December 20th, 2024 With 0.2 USD Dividend Per Share
December 10th (Eastern Time) - $ConMed(CNMD.US)$ is trading ex-dividend on December 20th, 2024.Shareholders of record on December 20th, 2024 will receive 0.2 USD dividend per share on January 3rd, 202
CONMED Keeps Quarterly Dividend at $0.20 Per Share; Payable Jan. 3 to Shareholders of Record on Dec. 20
Conmed Declares Dividend of 20c >CNMD
Press Release: CONMED Corporation Announces Quarterly Cash Dividend
Is CONMED Corporation's (NYSE:CNMD) 14% ROE Strong Compared To Its Industry?
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Conmed's BioBrace Implant Shows Promise but Awaits Crucial Trial Results Amid Financial Considerations
Why Conmed (CNMD) Is a Top Growth Stock for the Long-Term
Top 3 Health Care Stocks That May Dip This Month
CONMED (NYSE:CNMD) Seems To Use Debt Quite Sensibly
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
We Think That There Are Issues Underlying CONMED's (NYSE:CNMD) Earnings
Stifel Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $72
Results: CONMED Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates